Navigation Links
Bunge Reports Fourth Quarter Net Income of $245 Million
Date:2/7/2008

(1,743) (729)

Prepaid commodity purchase contracts (184) (88)

Secured advances to suppliers 207 256

Trade accounts payable 1,231 365

Unrealized net gain on derivative contracts (530) (184)

Margin deposits (175) (85)

Other - net 99 (320)

Cash used for operating activities (388) (289)

INVESTING ACTIVITIES

Payments made for capital expenditures (667) (503)

Investments in affiliates (39) (91)

Acquisitions of businesses (net of cash acquired)

and intangible assets (223) (74)

Proceeds from disposal of property, plant

and equipment 55 49

Related party loans (22) (21)

Return of capital from affiliate - 18

Proceeds from sale of investments 23 11

Cash used for investing activities (873) (611)

FINANCING ACTIVITIES

Net change in short-term debt 95 11

Proceeds from long-term debt 2,086 488

Repayments of long-term debt (1,203) (200)

Proceeds from sale of preference shares 845 677

Proceeds from sale of common shares 32 16

Dividends paid to preference shareholders (34) -

Dividends paid to common shareholders (80) (74)

Dividends paid to minority interest
'/>"/>

SOURCE Bunge Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
2. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
3. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
4. Recent Research Reports and Near-Term Corporate Events
5. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
6. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
7. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
8. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
9. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
10. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
11. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 16, 2014 “Never say, ‘I ... Universität Marburg’s Department of Physics, advises young women ... newly released SPIE Women in Optics 18-month ... shy to ask questions.” , In the annual ... mathematics) occupations ranging from university professor and laboratory ...
(Date:12/17/2014)... RIDGE, N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today ... mg (referred to as Somatuline®) was approved by ... the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in ... locally advanced or metastatic disease to improve progression-free ...
(Date:12/17/2014)... This report is a professional ... For an overview analysis, the report introduces quartz ... structure, industry overview, policy analysis, and news analysis, ... has witnessed rapid development with key manufacturers increasing ... report mentions quartz tubing upstream raw materials and ...
(Date:12/17/2014)... Park, CA (PRWEB) December 17, 2014 ... announces today that it has entered into a ... Midland Company (ADM) to apply DNA2.0’s proprietary protein ... enzyme engineering process. , “We are extremely excited ... ProteinGPS engineering platform. This proprietary bioengineering technology ...
Breaking Biology Technology:Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 82020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
... -- Company provides revenue guidance and strategic plan ... /PRNewswire-FirstCall/ - Neptune Technologies &,Bioressources Inc. ("Neptune") (NASDAQ.NEPT ... fourth quarter and year ended May 31, 2008. ... of fiscal year 2008,and has achieved its sixth ...
... 28 deCODE genetics,(Nasdaq: DCGN ) today announced ... Jeffrey Gulcher,s presentation at Thomas Weisel Partners Healthcare,Conference 2008., ... ET / 5:30 PM GMT / 6:30,PM British Summer ... Hotel,Boston, MA. The webcast can be accessed through the ...
... again included,Baxa Corporation on its annual ranking of the ... 4,611 and was among the top,five industries ranked on ... founding in 1975 and currently employs more than 450 ... "The Inc 5000 list promotes the very best in ...
Cached Biology Technology:Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results 2Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results 3Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results 4Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results 5Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results 6deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008 2Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US 2
(Date:12/19/2014)... , Dec. 18, 2014  23andMe, Inc., the ... a study that pinpoints fine-scale differences in genetic ancestry ... . Since immigrants first arrived more ... States has served as a meeting place ... American history and the ongoing mixing of peoples with ...
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB ... Good Clinical Practices (GCP) audit to confirm its ... (FDA) regulations. This accomplishment enables HITLAB to conduct ... utilizing the highest principles for patient safety and ... improve global healthcare access, quality, and delivery with ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... University of Southampton, which examines how dolphins might process their ... to detect targets, such as sea mines, in bubbly water. ... ,bubble nets, around schools of fish, which force the fish ... pick off. However, such bubble nets would confound the best ...
... Hamburg, Hannover and Graz, as well as further partners, ... focus will be set on degradable magnesium implants. One ... to develop first prototypes of orthopedic implants. Since ... a new Helmholtz Virtual Institute that will evolve in ...
... National data indicate that milk consumption has declined among ... quality has more than doubled. Although this suggests that ... children,s diets, a new study suggests that in fact ... to changes in their consumption of sodas and flavored ...
Cached Biology News:Do dolphins think nonlinearly? 2Do dolphins think nonlinearly? 3New research association started: Magnesium implants shall facilitate bone fracture healing 2Sugar-sweetened drinks are not replacing milk in kid's diets 2Sugar-sweetened drinks are not replacing milk in kid's diets 3
... camera controller is the successor to the original ... any of the cameras in the Nikon DS ... USB2.0 interface. The DS-U2 transmits information at high ... equipping both hub and mass storage USB 2.0 ...
... The Helios gene gun low-pressure system, 100-120 ... of biomaterials into cells. The system includes ... helium regulator, tubing prep station, syringe kit, ... low-pressure regulator, and instructions. The dimensions of ...
... gene gun optimization kit provides a variety ... affecting particle delivery with the Helios gene ... of 0.6 micrometer, 1.0 micrometer, and 1.6 ... cartridge kit, that provides 0.5 g polyvinylpyrrolidone ...
... HEXALIGHT robot is based on PI's experience ... more than a decade. PI Hexapods were ... and antenna adjustments over wide ranges in ... degrees of freedom with 3 m minimum ...
Biology Products: